Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (172)

Clear all filters
Clear all filters

Ocaratuzumab

Immunotherapy (Monoclonal Antibody)

Therapeutic Category

Immunotherapy (Monoclonal Antibody)

Oncology Type

Hematologic (Lymphoma/CLL)

Drug Class / Mechanism

Anti-CD20 mAb

Ofatumumab

Immunotherapy (Monoclonal Antibody)

Therapeutic Category

Immunotherapy (Monoclonal Antibody)

Oncology Type

Hematologic (Lymphoma/CLL)

Drug Class / Mechanism

Anti-CD20 mAb

Olverembatinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Leukemia)

Drug Class / Mechanism

BCR-ABL Tyrosine Kinase Inhibitor

Oprozomib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Multiple Myeloma)

Drug Class / Mechanism

Proteasome Inhibitor

Orelabrutinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Lymphoma/CLL)

Drug Class / Mechanism

BTK Inhibitor

Pacritinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (MPN)

Drug Class / Mechanism

JAK Inhibitor

Panobinostat

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Lymphoma)

Drug Class / Mechanism

HDAC Inhibitor

Pexmetinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (AML)

Drug Class / Mechanism

FLT3 Inhibitor

PF-06821497 (EZH2 Inhibitor)

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic

Drug Class / Mechanism

EZH2 Inhibitor

Pirtobrutinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Lymphoma/CLL)

Drug Class / Mechanism

BTK Inhibitor

Pivekimab Sunirine

Targeted Therapy (Antibody-Drug Conjugate)

Therapeutic Category

Targeted Therapy (Antibody-Drug Conjugate)

Oncology Type

Hematologic

Drug Class / Mechanism

Anti-CD123 ADC, DNA-alkylating payload

Ponatinib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Hematologic (Leukemia)

Drug Class / Mechanism

BCR-ABL Tyrosine Kinase Inhibitor